Literature DB >> 2930571

A revised sequence of calf thymus glutaredoxin.

I A Papayannopoulos1, Z R Gan, W W Wells, K Biemann.   

Abstract

The previously published structure of the glutaredoxin from calf thymus [Klintrot et al., (1984) Eur. J. Biochem. 144, 417-423] was reinvestigated by tandem mass spectrometry and found to have an N-terminal Ac-Ala-Gln-Ala-... sequence and an additional four amino acids inserted between positions 67 and 68.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2930571     DOI: 10.1016/0006-291x(89)92272-9

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  6 in total

1.  Four decades of structure determination by mass spectrometry: from alkaloids to heparin.

Authors:  Klaus Biemann
Journal:  J Am Soc Mass Spectrom       Date:  2002-11       Impact factor: 3.109

2.  Complete 1H, 13C, and 15N NMR resonance assignments and secondary structure of human glutaredoxin in the fully reduced form.

Authors:  C Sun; A Holmgren; J H Bushweller
Journal:  Protein Sci       Date:  1997-02       Impact factor: 6.725

3.  Complete amino acid sequence of bovine glia maturation factor beta.

Authors:  R Lim; A Zaheer; W S Lane
Journal:  Proc Natl Acad Sci U S A       Date:  1990-07       Impact factor: 11.205

4.  Utility of N-peracetylation of proteins for their structure determination by mass spectrometry.

Authors:  R S Annan; K Biemann
Journal:  J Am Soc Mass Spectrom       Date:  1993-02       Impact factor: 3.109

5.  The primary structure and properties of thioltransferase (glutaredoxin) from human red blood cells.

Authors:  V V Papov; S A Gravina; J J Mieyal; K Biemann
Journal:  Protein Sci       Date:  1994-03       Impact factor: 6.725

6.  Glutaredoxin homolog encoded by vaccinia virus is a virion-associated enzyme with thioltransferase and dehydroascorbate reductase activities.

Authors:  B Y Ahn; B Moss
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-01       Impact factor: 11.205

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.